Magali Olivier

MutSpec: a Galaxy toolbox for streamlined analyses of somatic mutation spectra in human and mouse cancer genomes

Xavier Castells, Jiri Zavadil, Graham Byrnes, 2016, BMC Bioinformatics.

Somatic mutations in cancer prognosis and prediction: lessons from TP53 and EGFR genes

Magali Olivier, M. Olivier, P. Tanière, 2011, Current opinion in oncology.

Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods

Shunsuke Kato, Chikashi Ishioka, Sean V. Tavtigian, 2006, Nucleic acids research.

Predicting the transactivation activity of p53 missense mutants using a four‐body potential score derived from Delaunay tessellations

Shunsuke Kato, Chikashi Ishioka, Magali Olivier, 2006, Human mutation.

p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines.

Anita Langerød, Magali Olivier, Pierre Hainaut, 2011, Cancer letters.

TP53 mutations in human cancers: origins, consequences, and clinical use.

Magali Olivier, Pierre Hainaut, M. Olivier, 2010, Cold Spring Harbor perspectives in biology.

Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors

Martin Vingron, Thomas Zander, Yupeng Cun, 2018, Nature Communications.

TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data

Dmitriy Sonkin, Jiri Zavadil, Maude Ardin, 2016, Human mutation.

The Tumor Suppressor Gene TP53: Implications for Cancer Management and Therapy

Magali Olivier, Pierre Hainaut, M. Olivier, 2004, Critical reviews in clinical laboratory sciences.